SCHEMBL20354516

SCHEMBL20354516

Cc1ccc2c(c1)OCCN(C)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.47
DRD1 P21728 2/20 0.47
DRD4 P21917 2/20 0.47
DRD5 P21918 2/20 0.47
DRD3 P35462 2/20 0.47
RIPK1 Q13546 2/20 0.39
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20354517 0.86 RIPK1 (0.51) DRD2DRD1DRD4DRD5DRD3
SCHEMBL21526562 0.81 DRD1 (0.46) DRD2DRD1DRD4DRD5DRD3
SCHEMBL23774907 0.79 RIPK1 (0.40) RIPK1PIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL21553421 0.78 RIPK1 (0.36) DRD2DRD1DRD4DRD5DRD3
SCHEMBL29388834 0.77 MAOA (0.53) DRD2DRD1DRD4DRD5DRD3
SCHEMBL10455557 0.77 MAOA (0.53) DRD2DRD1DRD4DRD5DRD3
SCHEMBL21526504 0.75 HTT (0.44) DRD2DRD1DRD4DRD5DRD3
SCHEMBL24258522 0.75 CREBBP (0.65) RIPK1PIK3CAPIK3CBPIK3CGCREBBP
SCHEMBL257337 0.74 ALDH1A1 (0.44) ALDH1A1GAAMAPTHSD17B10PKM
SCHEMBL30236532 0.74 ALDH1A1 (0.44) ALDH1A1GAAMAPTHSD17B10PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3647311-B1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO LTD (CN) 2023-11-01 EP disclosed
EP-3932404-A1 METHOD FOR TREATING FATTY LIVER DISEASE AND/OR STEATOHEPATITIS Beijing Tide Pharmaceutical Co., Ltd. (CN) 2022-01-05 EP disclosed
EP-3647311-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2020-05-06 EP disclosed
WO-2019001572-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF 北京泰德制药股份有限公司 2019-01-03 WO disclosed
WO-2018124001-A1 BMP-SIGNAL-INHIBITING COMPOUND 国立研究開発法人理化学研究所 2018-07-05 WO disclosed